The revolution in microbiota research over the past decade has provided invaluable
knowledge about the function of the microbial species that inhabit the human body. It has …

The correlations between microbiota dysbiosis and cancer have gained extensive attention
and been widely explored. As a leading cancer diagnosis worldwide, lung cancer poses a …

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing lung disease of indeterminate
etiology and limited therapeutic options. The initiation, development, and progression of IPF …

Idiopathic pulmonary fibrosis (IPF) is an advancing and fatal lung disease with increasing
incidence and prevalence. Nintedanib and pirfenidone were approved by the FDA for the …

Idiopathic pulmonary fibrosis (IPF) is a chronic, debilitating, fibrotic lung disease leading to
respiratory failure and ultimately to death. Being the prototype of interstitial lung diseases …

Rationale: Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after
repeated exposure and sensitization to inhaled antigens. The lung microbiome is …

COVID‐19 is a pandemic infection of the respiratory system caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The viral ribonucleic acid (RNA) was …

All of humans and other mammalian species are colonized by some types of
microorganisms such as bacteria, archaea, unicellular eukaryotes like fungi and protozoa …

Background Microbial dysbiosis is a potential mediator of air pollution-induced adverse
outcomes. However, a systemic comparison of the lung and gut microbiome alterations and …

New evidence strongly discloses the pathogenesis of host-associated microbiomes in
respiratory diseases. The microbiome dysbiosis modulates the lung's behavior and …